MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer

Neuro Oncol. 2016 Apr;18(4):598-9. doi: 10.1093/neuonc/nov325. Epub 2016 Feb 23.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / genetics
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / secondary*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / radiotherapy
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Neoplasm Staging
  • Prognosis
  • Proto-Oncogene Proteins c-met / genetics*
  • Radiation Tolerance / genetics*
  • Radiotherapy / adverse effects*

Substances

  • Biomarkers, Tumor
  • MET protein, human
  • Proto-Oncogene Proteins c-met